None listed
Conditions
Brief summary
We hypothesized that in male patients with lumbosacral degenerative disease, a high velocity low amplitude spinal manipulation in the lumbosacral segment (pull-move technique), will produce an immediate change in functional capacity and on the mechanical behavior of the lumbar spine, affecting the subject's height .
Interventions
Spinal Manipulation (Pull-Move Technique) in the Treatment Group The Spinal Manipulation technique (pull-move) will be performed according to previous literature. The subject positions himself in a lateral decubitus position of the opposite side to the posteriority. The uppermost lower limb is flexed until mechanical impact and tension is caused in the fifth lumbar vertebra. The therapist stands facing the patient. The front leg is supported against the edge of the bed and the back leg is flexed with the tibia placed in the popliteal fossa. With the upper hand, the therapist controlls the subject's trunk. The forearm of the caudal hand makes contact with the sacroiliac joint, placing the index finger in the L5 spinous process. Three stages will follow from here: (a) placing the levers. After contacting with L5 from increased flexion of the hip, the therapist keeps the spine in a neutral position. Then, the therapist extends the patient's upper limb against the bed to carry out the rotation of the spine to L5 level; (b) reducing the slack. The therapist´s caudal hand directs L5 towards the ceiling, making contact with its spinous process and (c) thrust. The caudal hand pushes the pelvis in the ventral direction and directs the spinous process to revert the L5. The cephalic hand counter thrusted. The thrust should be short range and very fast. The protocol will last for two minutes approximately. Participants in this group will only receive a single spinal manipulation
Sponsors
Study design
Eligibility
Inclusion criteria
(a) males between 18-55 years of age; (b) standardised body mass index (between 20-25 kg/m2), (c) clinical diagnosis of lumbosacral degenerative disc disease.
Exclusion criteria
The exclusion factors for participation in the clinical trial are: (a) smokers; (b) history of alcoholism or alcohol consumption within 24 hours prior to data collection; (c) elite sports-people; (d) a diagnosis of median, fragmented or migrating herniation; (e) cauda equina syndrome; (f) general contraindications to spinal manipulatio, eg tumour diseases and ankylosing spondylitis, among others;19 (g) previous degenerative disc surgery; and (h) spinal manipulation treatment within three months prior to the study.